Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IBRX | KRYS | KYMR | ||
| Company | Immunitybio Inc | Krystal Biotech Inc | Kymera Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.89 | 252.62 | 82.78 | ||
| High | 7.35 | 260.99 | 85.65 | ||
| Low | 6.88 | 252.62 | 82.67 | ||
| Latest | 7.30 | 260.95 | 85.40 | ||
| Change | +0.16 | +2.04 | +0.47 | ||
| % Change | +2.24% | +0.79% | +0.55% | ||
| Volume | 14,223,000 | 203,700 | 690,900 | ||
| 20-Day Average Volume | 26,015,820 | 286,595 | 674,595 | ||
| Previous Close | 7.14 | 258.91 | 84.93 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.01 | 253.40 | 80.52 | ||
| 20-Day Raw Stochastic | 25.33% | 80.13% | 88.85% | ||
| 20-Day Relative Strength | 48.53 | 51.53 | 56.23 | ||
| Weighted Alpha | +2.72 | +64.34 | +125.74 | ||
| Today's Opinion | 56% Buy | 56% Buy | 72% Buy | ||
| Previous Opinion | 56% Buy | 56% Buy | 72% Buy | ||
| Last Month's Opinion | 100% Buy | 64% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.08% since 03/26/26 | +3.80% since 03/26/26 | +6.51% since 03/26/26 | ||
| Low | 6.57 on 03/30/26 | 242.00 on 03/31/26 | 77.46 on 03/30/26 | ||
| High | 7.85 on 04/01/26 | 264.00 on 04/01/26 | 86.78 on 04/01/26 | ||
| 1-Month | |||||
| %Chg | -30.08% since 03/02/26 | +0.83% since 03/02/26 | -5.22% since 03/02/26 | ||
| Low | 6.54 on 03/24/26 | 242.00 on 03/31/26 | 73.31 on 03/24/26 | ||
| High | 10.58 on 03/03/26 | 268.26 on 03/03/26 | 89.19 on 03/03/26 | ||
| 3-Month | |||||
| %Chg | +261.39% since 01/02/26 | +5.69% since 01/02/26 | +17.37% since 01/02/26 | ||
| Low | 2.03 on 01/05/26 | 235.60 on 01/05/26 | 66.21 on 01/20/26 | ||
| High | 12.43 on 02/25/26 | 298.30 on 02/17/26 | 95.90 on 02/26/26 | ||
| 6-Month | |||||
| %Chg | +192.00% since 10/02/25 | +43.62% since 10/02/25 | +52.50% since 10/02/25 | ||
| Low | 1.95 on 12/31/25 | 179.16 on 10/03/25 | 55.26 on 10/23/25 | ||
| High | 12.43 on 02/25/26 | 298.30 on 02/17/26 | 103.00 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,505,210 | 7,628,091 | 6,972,226 | ||
| Shares Outstanding, K | 1,028,111 | 29,232 | 81,642 | ||
| Annual Sales | 113,290,000 | 389,130,000 | 39,210,000 | ||
| Annual Net Income | -351,400,000 | 204,830,000 | -311,350,000 | ||
| Last Quarter Sales | 38,290,000 | 107,110,000 | 2,870,000 | ||
| Last Quarter Net Income | -61,940,000 | 51,400,000 | -86,980,000 | ||
| 60-Month Beta | 0.13 | 0.54 | 2.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 02/23/26 | 1.70 on 02/17/26 | -0.97 on 02/26/26 | ||
| Latest Earnings Date | 05/11/26 | 05/05/26 | 05/08/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 37.80 | 0.00 | ||